Skip to main content
Shilpa Medicare Ltd. logo

Shilpa Medicare Ltd. — Investor Relations & Filings

Ticker · SHILPAMED ISIN · INE790G01031 LEI · 3358002PKUL8S2RNJO60 BSE.NS Manufacturing
Open in API
Filings indexed 817 across all filing types
Latest filing 2025-08-12 Capital/Financing Update
Country IN India
Listing BSE.NS SHILPAMED

About Shilpa Medicare Ltd.

https://vbshilpa.com/

Shilpa Medicare Ltd. is a research-led organization specializing in the development, manufacture, and commercialization of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company maintains a significant focus on the oncology segment, producing a wide range of high-potency anti-cancer drugs. Its capabilities extend to diverse therapeutic areas, including ophthalmology, dermatology, and biosimilars. Shilpa Medicare operates manufacturing facilities compliant with international regulatory standards such as the USFDA and EU-GMP. The organization emphasizes complex chemistry and advanced drug delivery systems, offering a portfolio that includes oral solids, injectables, and transdermal patches. Through its R&D infrastructure, the company provides contract research and manufacturing services to global partners, supporting the lifecycle of generic and innovative pharmaceutical products.

Recent filings

Filing Released Lang Actions
General Updates
Capital/Financing Update Classification · 100% confidence The document is a formal disclosure letter addressed to stock exchanges regarding the redemption of Non-Convertible Debentures (NCDs) by a subsidiary company. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to material event disclosures. The content is an update on a financing event (redemption of debt securities) rather than a full financial report or audit. The document length is short (1610 characters), and it serves as an announcement of a capital/financing event. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2025-08-12 English
Product launch
Regulatory Filings Classification · 95% confidence The document is a formal announcement from Shilpa Medicare Limited addressed to stock exchanges, informing about the approval of a new pharmaceutical product (Nor Ursodeoxycholic Acid Tablets 500 mg) by the Central Drugs Standard Control Organization (CDSCO). It highlights the significance of the approval, product details, and a statement from the Managing Director. The document is relatively short (4205 characters) and does not contain financial data, financial statements, or detailed financial analysis. It is an informational regulatory announcement about a product approval, not a financial report, earnings release, or management discussion. It also includes a compliance officer's signature, indicating it is an official regulatory filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-08-09 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-08-08 English
Board Meeting — Bonus
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying them of an upcoming Board Meeting scheduled for 13 August 2025. The purpose of the meeting includes considering and approving a proposal for issuing Bonus shares. It also mentions the closure of the trading window in compliance with insider trading regulations. The document references regulatory compliance (SEBI Listing Obligations and Disclosure Requirements Regulations, 2015) and insider trading rules but does not contain any financial statements, detailed financial data, or results. The document is short (1858 characters) and serves as an announcement of a board meeting and related regulatory compliance, not a report or detailed financial disclosure. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes or meetings of the board of directors or senior management.
2025-08-08 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification dated August 6, 2025, from Shilpa Medicare Limited to stock exchanges about the schedule of an upcoming earnings conference call for the first quarter of fiscal year 2025-26. It includes details about the call timing, dial-in numbers, and a brief company description. There are no financial statements or detailed financial data presented in the document. The document serves as an announcement of the earnings call event rather than the call transcript or the earnings release itself. Given the document length is 3112 characters (under 5000) and it primarily announces the schedule of the earnings call, it fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement rather than a Call Transcript (CT) or Earnings Release (ER).
2025-08-06 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a letter from Shilpa Medicare Limited addressed to stock exchanges notifying about an upcoming Board Meeting scheduled to consider and approve unaudited financial results for the quarter ended June 30, 2025. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events or information by listed entities. The document does not contain the financial results themselves but is an intimation or announcement of the meeting where such results will be approved. The document length is short (1875 characters) and it serves as a notification rather than the actual financial report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and disclosure, not as an Interim/Quarterly Report (IR) or Earnings Release (ER).
2025-08-05 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.